298 related articles for article (PubMed ID: 21466443)
1. Fractalkine/CX3CR1 signalling in chronic pain and inflammation.
Clark AK; Staniland AA; Malcangio M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1707-14. PubMed ID: 21466443
[TBL] [Abstract][Full Text] [Related]
2. Microglial signalling mechanisms: Cathepsin S and Fractalkine.
Clark AK; Malcangio M
Exp Neurol; 2012 Apr; 234(2):283-92. PubMed ID: 21946268
[TBL] [Abstract][Full Text] [Related]
3. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
4. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.
Yang XP; Mattagajasingh S; Su S; Chen G; Cai Z; Fox-Talbot K; Irani K; Becker LC
Circ Res; 2007 Nov; 101(10):1001-8. PubMed ID: 17885215
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.
Zanchi C; Zoja C; Morigi M; Valsecchi F; Liu XY; Rottoli D; Locatelli M; Buelli S; Pezzotta A; Mapelli P; Geelen J; Remuzzi G; Hawiger J
J Immunol; 2008 Jul; 181(2):1460-9. PubMed ID: 18606701
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
Huang L; Ma B; Ma J; Wang F
Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H
Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309
[TBL] [Abstract][Full Text] [Related]
8. Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.
Song KH; Park J; Park JH; Natarajan R; Ha H
Diabetologia; 2013 Jul; 56(7):1661-9. PubMed ID: 23604552
[TBL] [Abstract][Full Text] [Related]
9. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the fractalkine chemokine domain. Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion.
Harrison JK; Fong AM; Swain PA; Chen S; Yu YR; Salafranca MN; Greenleaf WB; Imai T; Patel DD
J Biol Chem; 2001 Jun; 276(24):21632-41. PubMed ID: 11278650
[TBL] [Abstract][Full Text] [Related]
11. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
Szukiewicz D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
[TBL] [Abstract][Full Text] [Related]
12. Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.
Fujita M; Takada YK; Takada Y
J Immunol; 2012 Dec; 189(12):5809-19. PubMed ID: 23125415
[TBL] [Abstract][Full Text] [Related]
13. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
[TBL] [Abstract][Full Text] [Related]
14. Modulation of inflammatory responses by fractalkine signaling in microglia.
Inoue K; Morimoto H; Ohgidani M; Ueki T
PLoS One; 2021; 16(5):e0252118. PubMed ID: 34019594
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid-contacting nucleus mediates nociception via release of fractalkine.
Zhou QQ; Chen SS; Zhang QQ; Liu PF; Fang HZ; Yang Y; Zhang LC
Braz J Med Biol Res; 2017 Aug; 50(9):e6275. PubMed ID: 28793053
[TBL] [Abstract][Full Text] [Related]
16. FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats.
Zhou Y; Zhang L; Hao Y; Yang L; Fan S; Xiao Z
J Headache Pain; 2022 Apr; 23(1):42. PubMed ID: 35382731
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.
D'Haese JG; Friess H; Ceyhan GO
Expert Opin Ther Targets; 2012 Jun; 16(6):613-8. PubMed ID: 22530606
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine upregulates inflammation through CX3CR1 and the Jak-Stat pathway in severe acute pancreatitis rat model.
Huang LY; Chen P; Xu LX; Zhou YF; Zhang YP; Yuan YZ
Inflammation; 2012 Jun; 35(3):1023-30. PubMed ID: 22213034
[TBL] [Abstract][Full Text] [Related]
19. Microglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits.
Ru W; Liu X; Bae C; Shi Y; Walikonis R; Mo Chung J; Tang SJ
J Neurosci; 2019 Oct; 39(42):8408-8421. PubMed ID: 31471472
[TBL] [Abstract][Full Text] [Related]
20. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
